Mortality Risk Scores

• General outpatients, inpatients, and ED patients with any diagnosis Horne BD, et al. Am J Med 2009;122:550-558


• General population, randomly selected non-patient individuals (NHANES III study) Horne BD, et al. Am J Med 2009;122:550-558


• People without cardiovascular disease enrolled in large 26-nation randomized trial (JUPITER Trial):
• All-cause mortality score
• Cardiovascular mortality score
• Combination of mortality, myocardial infarction, stroke, hospitalization for unstable angina, or coronary revascularization
Horne BD, et al. Eur J Prev Cardiol 2015; 22:519-526


• Expanded IMRS, using the comprehensive metabolic profile (instead of basic metabolic profile)
  May HT, et al. Clin Chem Lab Med 2016;54:1619-1628.

• Implantable Cardioverter-Defibrillator (ICD) recipients Brunisholz KD, et al. J Card Fail 2011;17 (suppl):S74 (abstr)


• Coronary angiogram patients Horne BD, et al. Transl Res 2011;158:307-314.


• Two populations of Heart Failure patients Brunisholz KD, et al. J Heart Lung Transplant 2012;31(4S):S53 (abstr)
  Horne BD, et al. Eur J Heart Fail 2010;12:1203-1213


• Left Ventricular Assist Device (LVAD) recipients at Intermountain Healthcare and Montefiore Medical Center (NY) Mannem SR, et al. J Am Coll Cardiol 2014; 63(12_S):A220 (abstr)


• Cardiac Transplant patients Brunisholz KD, et al. J Heart Lung Transplant 2011;30(4S):S47-S48 (abstr)


• Percutaneous Coronary Intervention Patients (all-cause in-hospital mortality) Horne BD, et al. Circulation 2014;130:A12446 (abstr)


• Cardiac Surgery populations at Intermountain Healthcare and BrazilJohnson EG, et al. J Am Coll Cardiol 2013;61 (suppl A):A397 (abstr)Rödel APP, et al. Int J Cardiol 2015;187:60-62

The IMACE Risk Scores are sex-specific models that predict the combination of cardiovascular mortality, myocardial infarction, and stroke 1-3 years after MI or stent.

• IMACE for post-MI patients Horne BD, et al. Circulation 2015;132(suppl 3):A14907 (abstr)


• IMACE for post-stent patients